Disease: Triglycerides measurement
Source: ALL
Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Num. diseases
rs17883880
CHUK
10 100230590 intron variant T/A snv 1.2E-02 4
rs8071787
GAS7
17 10058819 intron variant T/C snv 4.8E-02 5
rs11571151
PGR-AS1 ; PGR
11 101127486 missense variant C/G;T snv 6
rs11828157
MMP13
11 102947395 intron variant G/A snv 4.7E-02 5
rs675504 11 102959002 upstream gene variant A/G snv 0.98 5
rs11193085
SORCS1
10 106873848 intron variant G/A snv 8.8E-02 3
rs585362 1 109247173 upstream gene variant C/G;T snv 4
rs4970834
CELSR2
0.925 0.160 1 109272258 intron variant C/T snv 0.17 0.21 8
rs611917
CELSR2
1.000 0.040 1 109272630 non coding transcript exon variant A/G snv 0.28 0.32 5
rs629301
CELSR2
0.851 0.120 1 109275684 3 prime UTR variant G/T snv 0.74 22
rs11668477 0.925 0.080 19 11084354 downstream gene variant A/G snv 0.34 7
rs6511720
LDLR
0.790 0.120 19 11091630 intron variant G/T snv 0.12 15
rs2255141
GPAM
10 112174128 intron variant A/G;T snv 5
rs3093267
F7
13 113118661 missense variant G/A;T snv 8.0E-05 6
rs9326246 0.925 0.040 11 116741017 intergenic variant C/G snv 0.93 9
rs964184
ZPR1
0.716 0.440 11 116778201 3 prime UTR variant G/C snv 0.82 47
rs6589566
ZPR1
0.882 0.080 11 116781707 intron variant G/A;C;T snv 10
rs17120434
PCSK7 ; TAGLN
11 117204969 3 prime UTR variant A/G;T snv 5.4E-02 3
rs9658465
NOS1
12 117247093 intron variant T/G snv 2.3E-02 3
rs9658292
NOS1
12 117318980 intron variant G/C snv 9.4E-04 5
rs2001945 8 125465736 upstream gene variant G/A;C;T snv 10
rs2001844 0.882 0.040 8 125466503 upstream gene variant A/G snv 0.43 9
rs6982636 8 125467073 intron variant G/A snv 0.43 7
rs2980880 8 125468730 intron variant G/A snv 0.69 6
rs2980875 8 125469505 intron variant A/C;G;T snv 6